PD-L1 immunostaining: what pathologists need to know.
Mohammed AkhtarSameera RashidIssam A Al-BozomPublished in: Diagnostic pathology (2021)
Immune checkpoint therapy appears to be promising and is rapidly expanding to include a large variety of cancers.